Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stake Reduced by Nuveen Asset Management LLC

Nuveen Asset Management LLC lowered its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 1.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,667,690 shares of the pharmacy operator's stock after selling 25,944 shares during the quarter. Nuveen Asset Management LLC owned 0.19% of Walgreens Boots Alliance worth $15,560,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of WBA. Golden State Wealth Management LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter valued at about $26,000. Riverview Trust Co raised its stake in Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,590 shares during the last quarter. Colonial Trust Co SC raised its stake in Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,297 shares during the last quarter. Venturi Wealth Management LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter valued at about $28,000. Finally, Independence Bank of Kentucky acquired a new position in Walgreens Boots Alliance in the 4th quarter valued at about $39,000. Institutional investors and hedge funds own 58.59% of the company's stock.

Analyst Ratings Changes

Several brokerages recently weighed in on WBA. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and cut their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Wall Street Zen initiated coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating for the company. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Finally, Truist Financial lowered their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Stock Down 0.2%

Shares of WBA traded down $0.02 during trading on Wednesday, reaching $11.19. The company's stock had a trading volume of 8,657,737 shares, compared to its average volume of 20,865,684. The company has a fifty day moving average of $11.03 and a two-hundred day moving average of $10.45. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $16.34. The company has a market cap of $9.68 billion, a price-to-earnings ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.77. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. During the same period in the prior year, the company posted $1.20 EPS. Walgreens Boots Alliance's quarterly revenue was up 4.1% on a year-over-year basis. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Insider Activity

In other news, Chairman Stefano Pessina purchased 832,258 shares of the stock in a transaction dated Sunday, April 27th. The stock was acquired at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the acquisition, the chairman now owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. The trade was a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 17.50% of the company's stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.